ASLAN Pharmaceuticals Ltd (ASLN)
0.41
+0.01
(+2.22%)
USD |
NASDAQ |
Jun 14, 16:00
0.42
+0.01
(+2.44%)
After-Hours: 20:00
ASLAN Pharmaceuticals Revenue (Annual): 12.00M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 12.00M |
December 31, 2022 | |
December 31, 2021 | |
December 31, 2020 |
Date | Value |
---|---|
December 31, 2019 | 3.00M |
December 31, 2018 | |
December 31, 2017 | |
December 31, 2016 | 11.55M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
3.00M
Minimum
2019
12.00M
Maximum
2023
7.50M
Average
7.50M
Median
Revenue (Annual) Benchmarks
Dr Reddy's Laboratories Ltd | 3.372B |
Concord Medical Services Holdings Ltd | 75.97M |
Zai Lab Ltd | 266.72M |
WAVE Life Sciences Ltd | 113.30M |
CytoMed Therapeutics Ltd | -- |